Application of adenosine 5′-triphosphate (ATP) infusions in palliative home care: Design of a randomized clinical trial

BMC Public Health

Volumn 7, Issue , 2007, Pages

  Beijer, Sandra ^a   Van Rossum, Erik ^a   Hupperets, Pierre S ^b   Spreeuwenberg, Cor ^a   Van Beuken, Marieke Den ^b   Winkens, Ron A ^b   Ars, Lisette ^c   Van Den Borne, Ben E ^d   De Graeff, Alexander ^e   Dagnelie, Pieter C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GroenekruisDomicura Maastricht and Area   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ARTICLE; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG INFUSION; FOLLOW UP; HEALTH SERVICE; HOME CARE; HUMAN; INTERVENTION STUDY; LUNG NON SMALL CELL CANCER; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TERMINALLY ILL PATIENT; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; BODY HEIGHT; BODY WEIGHT; COMPLICATION; COST OF ILLNESS; DRUG EFFECTS; FATIGUE; FEASIBILITY STUDY; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUMOR; METHODOLOGY; MUSCLE STRENGTH; MUSCLE WEAKNESS; NETHERLANDS; NON SMALL CELL LUNG CANCER; PALLIATIVE THERAPY; PATIENT SELECTION; PROCEDURES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TERMINAL CARE;

ADENOSINE TRIPHOSPHATE; BODY HEIGHT; BODY WEIGHT; CARCINOMA, NON-SMALL-CELL LUNG; COST OF ILLNESS; FATIGUE; FEASIBILITY STUDIES; HOME CARE SERVICES; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MUSCLE STRENGTH; MUSCLE WEAKNESS; NETHERLANDS; PALLIATIVE CARE; PATIENT SELECTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TERMINAL CARE; TREATMENT OUTCOME;

EID: 33846939602     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-7-4     Document Type: Article

References (31)

1. Sepulveda C, Marlin A, Yoshida T, Ullrich A: Palliative Care: the World Health Organization's global perspective. J Pain Symptom Manage 2002, 24:91-96.
2. Lundh Hagelin C, Seiger A, Furst CJ: Quality of life in terminal care - with special reference to age, gender and marital status. Support Care Cancer 2006, 14:320-328.
3. Courtens AM: Kenmerken van zorg en kwaliteit van leven bij patiënten met kanker. Proefschrift 1993, Universitaire Pers Maastricht:.
4. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH: Adenosine triphosphate: established and potential clinical applications. Drugs 1999, 58:211-232.
5. Agteresch HJ, Dagnelie PC, van Der Gaast A, Stijnen T, Wilson JH: Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 2000, 92:321-328.
6. Agteresch HJ, Dagnelie PC, Rietveld T, van den Berg JW, Danser AH, Wilson JH: Pharmacokinetics of intravenous ATP in cancer patients. Eur J Clin Pharmacol 2000, 56:49-55.
7. Freilich A, Tepper D: Adenosine and its cardiovascular effects. Am Heart J 1992, 123:1324-1328.
8. Zhang C: [Electrophysiological effects of different dosage of adenosine triphosphate on normal sinoatrial and atrioventricular node]. Chung Hua Hsin Hsueh Kuan Ping Tsa Chih 1992, 20:98-100, 134.
9. van Halteren HK, Bongaerts GP, Wagener DJ: Cancer cachexia: what is known about its etiology and what should be the current treatment approach? Anticancer Res 2003, 23:5111-5115.
10. National Cancer Institute. Common Toxicity Criteria, version 2.0. Publish date: April 30, 1999.
11. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al.: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376.
12. Aaronson NK, Cull AM, Kaasa S, Sprangers MAG: The European Organization for Research and Treatment of Canncer (EORTC) Modular Approach to Quality of Life Assessment in Oncology: An Update. Quality of Life and Pharmacoeconomics in Clinical Trials 1996, Second Edition, Chapter 21:179-189.
13. Kyriaki M, Eleni T, Efi P, Ourania K, Vassilios S, Lambros V: The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care: validity and reliability in a Hellenic sample. Int J Cancer 2001, 94:135-139.
14. Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, Kvikstad A: The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 1995, 31a:2260-2263.
15. de Haes JC, van Knippenberg FC, Neijt JP: Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990, 62:1034-1038.
16. Alberts M, Smets EM, Vercoulen JH, Garssen B, Bleijenberg G: 'Verkorte vermoeidheidsvragenlijst': een praktisch hulpmiddel bij het scoren van vermoeidheid. NTVG 1997, 141:1526-1530.
17. Kempen GI, Miedema I, Ormel J, Molenaar W: The assessment of disability with the Groningen Activity Restriction Scale. Conceptual framework and psychometric properties. Soc Sci Med 1996, 43:1601-1610.
18. Kempen GIJM, Doeglas DM, Suurmeijer TPBM: Groningen Activiteiten Restrictie Schaal (GARS): een handleiding. Groningen, Rijksuniversiteit Groningen; 1993.
19. Suurmeijer TP, Doeglas DM, Moum T, Briancon S, Krol B, Sanderman R, Guillemin F, Bjelle A, van den Heuvel WJ: The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons. Am J Public Health 1994, 84:1270-1273.
20. de Graaf C: The validity of appetite ratings. Appetite 1993, 21:156-160.
21. Raben A, Tagliabue A, Astrup A: The reproducibility of subjective appetite scores. Br J Nutr 1995, 73:517-530.
22. Stubbs RJ, Hughes DA, Johnstone AM, Rowley E, Reid C, Elia M, Stratton R, Delargy H, King N, Blundell JE: The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br J Nutr 2000, 84:405-415.
23. Bingham S.A. NM Paul A.A, Haraldsdottir J, Bjorge Loken E, van Staveren W.A.: Methods for data collection at an individual level. In Manual on methodology for food consumption studies Edited by: Cameron M.E SWA. Oxford, Oxford University Press; 1988:53-106.
24. Hill RJ, Davies PS: The validity of self-reported energy intake as determined using the doubly labelled water technique. Br J Nutr 2001, 85:415-430.
25. Durnin JV, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974, 32:77-97.
26. Gurney JM, Jelliffe DB: Arm anthropometry in nutritional assessment: nomogram for rapid calculation of muscle circumference and cross-sectional muscle and fat areas. Am J Clin Nutr 1973, 26:912-915.
27. Bohannon RW: Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years. Arch Phys Med Rehabil 1997, 78:26-32.
28. Kwoh CK, Petrick MA, Munin MC: Inter-rater reliability for function and strength measurements in the acute care hospital after elective hip and knee arthroplasty. Arthritis Care Res 1997, 10:128-134.
29. Roy MA, Doherty TJ: Reliability of hand-held dynamometry in assessment of knee extensor strength after hip fracture. Am J Phys Med Rehabil 2004, 83:813-818.
30. Wang AY, Sea MM, Ho ZS, Lui SF, Li PK, Woo J: Evaluation of handgrip strength as a nutritional marker and prognostic indicator in peritoneal dialysis patients. Am J Clin Nutr 2005, 81:79-86.
31. Rantanen T, Volpato S, Ferrucci L, Heikkinen E, Fried LP, Guralnik JM: Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc 2003, 51:636-641.